SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending as discussions revolve around its potential role in the Real World Asset (RWA) space, with some community members envisioning tokenized assets like houses being used as collateral on its blockchain. However, concerns persist regarding the project's revenue and financial sustainability, with some users pointing to its cashflow and governance as potential issues. Overall, there is much debate around the future of the project and its place in the evolving crypto landscape.

“Hmmm” is a community meme token on the Solana network, launched on July 22, 2024, through Pumpfun. It’s a derivative of Pepe the Frog but has evolved into its own distinct meme with a unique identity. The token embraces the humor and intrigue of internet culture, playing on the idea of curiosity and speculation. “Hmmm” captures a playful approach to the world of meme tokens, designed to engage a community driven by fun and the whimsical side of crypto. Hmmm, maybe this’ll send.

hmmm

HMMM crypto is trending amid community excitement, with discussions centered on potential 'rocket mode' and 'moon vibes'. The focus is on its integration with Phantom Wallet and its relationship with other cryptos like BTC and SOL.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol ($VIRTUAL) is trending amid discussions about its role in bridging blockchain with gaming and AI, with community members highlighting its potential in the expanding play-to-earn and virtual world sectors. The community is actively discussing new exchange listings and the potential for significant growth, while also debating its long-term value and speculating on potential price targets. Some users are taking profits from other crypto holdings to invest in $VIRTUAL, citing its technology enabling tokenized economies and real ownership of digital assets.

Clanker is an autonomous agent for deploying tokens. Currently, users may request clanker to deploy an ERC-20 token on Base by tagging it @clanker on Farcaster.

tokenbot

Clanker Crypto ($CLANKER) is trending amid community discussions about potential Coinbase-related maintenance impacting trading. Some users are reporting order issues, while others highlight the token's low supply and potential for significant price movement. The coin's breakout from a descending triangle is being watched by traders.

About Mistery On Cro $MERY was born with the idea of being a meme coin on Cronos chain during the exploding 2024 meme coin season. The founder is David Bui, a well-known and seasoned #crofam $CRO investor on Cryptocom products and a big -well respected- personality on X. David minted “Mistery On CRO” on Cronos blockchain with the purpose of making this chain much better, more popular and specially more fun, but aside from serving as a mere “meme”, $MERY has the ultimate goal of also being a utility token that the founder and the team behind will push to bring many benefits to loyal hodlers. Launched in 27/3/2024 at Sydney, Australia, local time 21h00, the 690,000 $CRO presale sold out within 2 hours. The founder burned the LP to a dead wallet and the contract ownership was renounced. $MERY during its first week of launch got instant traction from the OG #crofam community who jumped in and secured bags. We are now a thriving community that will help nurturing and growing the project by sharing with more and more Web3 users.

Mistery

$MERY is trending as community members highlight its connection to $CRO, with some suggesting the two move in tandem.  Enthusiasm is fueled by a new listing on Hibt and mentions of a recently launched game, prompting users to declare it's "moonish" time. The conversation includes bullish sentiment, with many noting that crypto.com owns a significant portion of the coin.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

GBTC is trending as Bitcoin approaches previous all-time highs, fueling discussions about future price targets and potential parabolic movement. Community members are weighing GBTC against other Bitcoin investment options, including ETFs, and debating its long-term value as a hedge against economic uncertainty. Some are also excited about Grayscale adding SUI to their GSCPxE Fund.

NXP Semiconductors NV is a holding company which engages in the provision of semiconductor solutions. It operates through the following geographical segments: China, Netherlands, United States, Singapore, Germany, Japan, South Korea, Malaysia, and Other Countries. The company was founded on August 2, 2006, and is headquartered in Eindhoven, the Netherlands.

NXP Semiconductors NV

NXPI is trending as analysts update their ratings, with a focus on automotive and mobile sector growth potential. The community is discussing whether the stock is undervalued, while also noting the company's upcoming earnings call. Some are also pointing to the broader strength in semi chains.

Roundhill ETF Trust - Roundhill WeeklyPay Universe ETF

Roundhill WeeklyPay™ Universe ETF

$WPAY is trending as investors discuss its weekly dividend payouts and compare it to other high-yield ETFs like $ULTY and $MAGY. The ETF's steady performance and upcoming inclusion of four new weekly-paying ETFs are generating excitement within the community. Some investors are rotating out of other income-generating assets to increase their positions in $WPAY.

PayPal USD is designed to contribute to the opportunity stablecoins offer for payments and is 100% backed by U.S. dollar deposits, short-term U.S Treasuries and similar cash equivalents. PayPal USD is redeemable 1:1 for U.S. dollars and is issued by Paxos Trust Company.

PayPal USD

PayPal's PYUSD is trending amid discussions about its market capitalization, potential integration with various blockchain networks like Stellar and Solana, and its role in cross-border payments. Community members are actively debating its growth prospects, regulatory compliance, and how it stacks up against other stablecoins. Recent news includes a minting error and analysis of PayPal's overall strategy, which has further fueled the conversation.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking Inc. is trending due to high volatility and significant price swings, drawing attention from day traders and swing traders seeking quick profits. Community discussions revolve around potential short squeezes, halt resumptions, and speculation about after-hours trading. Some traders caution about the stock being a Chinese textile manufacturer, while others see potential for further upward movement given its low float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. biotech stocks, particularly small and mid-cap companies, remained a focal point for retail investors in 2024 despite significant volatility.&nbsp;Collectively, biotech stocks on U.S. bourses have garnered over 3.3 million watchers on Stocktwits.&nbsp;Here are the top five biotech stocks that saw the most significant surge in new followers this year:CERo Therapeutics Holdings Inc. (CERO): +44544% WatchersThis immunotherapy company develops engineered T-cell therapeutics for cancer. <a href="https://stocktwits.com/symbol/CERO">CERO</a> saw major retail interest following the FDA’s clearance of its lead compound, CER-1236, for Phase 1 clinical trials after an earlier clinical hold. The company went public via a SPAC merger in February and has lost 99% of its value this year.Psyence Biomedical Ltd. (PBM): +6741% WatchersKnown for developing natural psilocybin products for treating psychological trauma, PBM gained attention for positive results from its Phase IIb trial in adjustment disorder treatment for terminal cancer patients.&nbsp;Its&nbsp;shares have also dropped 99% this year since the company’s March SPAC debut.Azitra Inc. (AZTR): +2365% WatchersSpecializing in dermatological therapies using engineered proteins and live biotherapeutic products, AZTR drew attention for securing&nbsp;a fast track designation for ATR-04 and other multiple&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-are-azitra-shares-trending-on-wednesday/c7r4UW0RbE">patents</a>. Its stock value has plunged more than 99% since its debut in June last year.Immuneering Corporation (IMRX): +2248% WatchersFocused on oncology, IMRX’s lead program, IMM-1-104, received FDA orphan drug designation for pancreatic cancer and fast-track status to treat certain melanoma patients, and is currently in a Phase 2a trial. <a href="https://stocktwits.com/symbol/IMRX">IMRX shares</a> have declined over 70% year-to-date.NKGen Biotech Inc. (NKGN): +1260% WatchersNKGN develops autologous and CAR-NK cell therapies. Its SNK01 natural killer cell therapy for Alzheimer’s disease showed promising results, with 90% of patients maintaining or improving cognitive function. The candidate was cleared to progress into phase 2 clinical development, which will involve a larger group of 30 patients with moderate Alzheimer's disease. Shares, however, have fallen more than 66% this year.Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments, positioning them as key biotech names to watch heading into 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024

Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.

Equity

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.
read more...

Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care

Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.
read more...

Psyence Biomedical Shares Clinical Ambitions

Psyence Biomedical (PBM) has released an update. Psyence Biomedical Ltd. has released an investor presentation highlighting its focus on developing...

Psyence Biomedical Amends Note Agreements

Psyence Biomedical (PBM) has released an update. Psyence Biomedical Ltd. has entered into an addendum with note holders, facilitating the conversio...

Why Psyence Biomedical (PBM) Stock Is Skyrocketing

Psyence Biomedical shares are trading higher by 73% during Thursday's session. The company announced the export of nature-derived psilocybin to Australia.
read more...

Psyence Biomedical Issues Convertible Note

Psyence Biomedical (PBM) has released an update. Psyence Biomedical Ltd. has issued a Senior Secured Convertible Note due July 15, 2027, with a pri...

Fluence Partners with Psyence Biomed and iNGEN CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Fluence Partners with Psyence Biomed and iNGEN CRO to Train Research Therapists for Phase IIb Psilocybin Trial Fluence Partners with Psyence Biomed and iNGEN CRO to Train Research Therapists for...

Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin

The study, published in the journal Molecular Psychiatry, suggests that nature-derived psilocybin may be demonstrably more therapeutic than its synthetic analog Benefits are thought to include a...

Psyence Biomedical gets non-compliance notification from Nasdaq

Psyence Biomedical gets non-compliance notification from Nasdaq...

Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.

Psyence Biomedical Ltd.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	N/A
Prev Close	N/A
Open	N/A
Dividend Yield	0.00%
50-Day Moving Average	$3.38
Beta	1.90
Avg. Volume	1.4M
PE Ratio	-0.22

52-Week High	$63.36
52-Week Low	$2.36
Market Capitalization	$2.38M
EPS (Annual)	$1.78
Price to Book	-0.20
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

PBM
Psyence Biomedical Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest PBM News

PBMPsyence Biomedical Ltd.